SCHEMBL20090195

SCHEMBL20090195

S=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc3nc4c5ccc6ccccc6c5c5ccc(-c6cnc7cc(P(=S)(c8ccccc8)c8ccccc8)ccc7c6)cc5n4c3c2)nc1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20096347 0.96 PDGFRB (0.32) PIK3CDPIK3CA
SCHEMBL20096352 0.95
SCHEMBL20090202 0.95 CYP11B1 (0.32)
SCHEMBL20090250 0.93 PIK3CD (0.32) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL20090184 0.90 MTOR (0.31) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL20096520 0.90 PDGFRB (0.32) PIK3CDPIK3CA
SCHEMBL20096638 0.89
SCHEMBL20090254 0.88 CYP11B1 (0.32)
SCHEMBL20096407 0.88
SCHEMBL19960331 0.87 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 PIK3CD 4347/4885PIK3CA 4430/4885PIK3CB 4471/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 PIK3CD 4347/4885PIK3CA 4430/4885PIK3CB 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.